CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Shannon John Patrick Jr See Remarks | Option exercise | +64,265 | $1.55 | $100K | 2,769,611 |
| 2026-01-05 | Shannon John Patrick Jr See Remarks | Option exercise | +25,136 | $1.55 | $39K | 2,794,747 |
| 2026-01-05 | Shannon John Patrick Jr See Remarks | Option exercise | +2,900 | $3.94 | $11K | 2,797,647 |
| 2026-01-05 | Shannon John Patrick Jr See Remarks | Option exercise · Stock Option (Right to Buy) | −64,265 | 0 | ||
| 2026-01-05 | Shannon John Patrick Jr See Remarks | Option exercise · Stock Option (Right to Buy) | −25,136 | 0 | ||
| 2026-01-05 | Shannon John Patrick Jr See Remarks | Option exercise · Stock Option (Right to Buy) | −2,900 | 97,100 | ||
| 2026-01-02 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $7.43 | $124K | 1,308,103 |
| 2025-12-19 | JOHNSON JOHN Director | Sale | −135,400 | $7.22 | $977K | 698,083 |
| 2025-12-12 | BORMANN-KENNEDY BARBARA-JEAN ANNE Director | Sale 10b5-1 | −15,000 | $7.09 | $106K | 142,500 |
| 2025-12-01 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $7.01 | $117K | 1,320,176 |
| 2025-11-14 | Shannon John Patrick Jr See Remarks | Option exercise | +87,100 | $1.55 | $135K | 2,730,253 |
| 2025-11-14 | Shannon John Patrick Jr See Remarks | Option exercise · Stock Option (Right to Buy) | −87,100 | 64,265 | ||
| 2025-11-13 | Shannon John Patrick Jr See Remarks | Option exercise | +8,970 | $1.55 | $14K | 2,666,395 |
| 2025-11-13 | Shannon John Patrick Jr See Remarks | Sale | −23,242 | $7.46 | $173K | 2,643,153 |
| 2025-11-13 | Shannon John Patrick Jr See Remarks | Option exercise · Stock Option (Right to Buy) | −8,970 | 151,365 | ||
| 2025-11-11 | Hecht Beth See Remarks | Sale 10b5-1 | −16,667 | $7.40 | $123K | 1,336,843 |
| 2025-10-02 | McCulloch Kevin See Remarks | Shares withheld for taxes | −733 | $8.31 | $6K | 1,700,426 |
| 2025-09-11 | McCulloch Kevin See Remarks | Other disposition | −2,000 | 0 | ||
| 2025-09-11 | PERSKY MARLA Director | Sale 10b5-1 | −15,500 | $7.72 | $120K | 142,000 |
| 2025-08-28 | SHERMAN JEFFREY W Director | Option exercise | +47,040 | $6.66 | $313K | 261,420 |
Page 5 of 10 · 200 trades